List withdrawn drugs of the market

Some Médicament S were withdrawn from the market after being introduced there because of risks for the patients.

Usually, they were unforeseen side effects which had not been detected at the time of the clinical trials and appeared only at the time of data resulting from the Pharmacovigilance or study of phase IV (Post-marketing).

Certain drugs were recently withdrawn from the market in France, in particular those which contained hidden antibiotics. For more details: the site of Afssaps

The 12 withdrawn are: Locabiotal 1%, Lysopaïne in tablet, Oropivalone bacitracin in tablet, Pharmacilline 0,25 per thousand out of bottle pulverizer, Argicilline 0,05 per thousand in nasal solution, Pharmacilline 0,05 per thousand in nasal solution, Solutricine evils of throat into compressed (and formulas without sugar and tetracaine), Ergix badly of throat in tablet, Veybirol tyrothricine in solution for bath of mouth and bituminous mix Tyrotricil compressed.

Withdrawals related to serious undesirable effects

Random links:Total hardness | Medal of Overseas | International airport of Viracopos/Campinas | Indicator (biodiversity) | Nechtan (Celtic god) | Wheatear_pie